ImmuCell Corporation (ICCC)

ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	32	39	47	62	43	37
Market Cap Growth	2.87%	-16.51%	-23.70%	44.32%	15.59%	-3.93%
Enterprise Value	47	55	54	62	46	37
PE Ratio	-	-6.83	-18.95	-791.09	-41.99	-28.66
PS Ratio	1.50	2.26	2.55	3.22	2.80	2.71
PB Ratio	1.30	1.58	1.56	1.90	1.52	1.28
P/FCF Ratio	-14.82	-6.01	-8.58	-37.78	-15.83	-52.45
P/OCF Ratio	-27.50	-8.44	-30.61	64.91	32.62	159.00
EV/Sales Ratio	2.22	3.16	2.91	3.22	2.98	2.68
EV/EBITDA Ratio	-48.38	-18.07	37202.79	25.93	34.75	36.78
EV/EBIT Ratio	-14.49	-9.56	-21.70	-897.26	-44.28	-29.02
EV/FCF Ratio	-20.34	-8.40	-9.79	-37.84	-16.86	-51.95
Debt / Equity Ratio	0.66	0.67	0.41	0.32	0.38	0.29
Debt / EBITDA Ratio	-13.96	-5.47	8606.72	4.30	8.16	8.42
Debt / FCF Ratio	-5.87	-2.54	-2.27	-6.27	-3.96	-11.90
Quick Ratio	0.86	0.75	2.46	5.08	4.41	4.17
Current Ratio	2.71	2.73	4.56	6.42	5.50	5.29
Asset Turnover	0.49	0.40	0.40	0.45	0.38	0.35
Return on Equity (ROE)	-15.20%	-21.80%	-7.80%	-0.30%	-3.60%	-4.40%
Return on Assets (ROA)	-8.90%	-13.20%	-5.40%	-0.20%	-2.50%	-3.30%
Return on Capital (ROIC)	-9.27%	-13.79%	-5.36%	0.60%	-3.54%	-2.55%
Earnings Yield	-12.17%	-14.64%	-5.28%	-0.13%	-2.38%	-3.49%
FCF Yield	-8.65%	-16.64%	-11.66%	-2.65%	-6.32%	-1.91%
Buyback Yield / Dilution	-0.05%	-0.03%	-2.01%	-5.25%	-5.78%	-24.29%
Total Shareholder Return	-0.05%	-0.03%	-2.01%	-5.25%	-5.78%	-24.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).